IL-YANG Quadrivalent Influenza Vaccine
Sponsors
Il-Yang Pharm. Co., Ltd.
Conditions
InfluenzaInfluenza, Human
Phase 3
Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'
CompletedNCT02677493
Start: 2015-10-31End: 2016-06-30Updated: 2023-09-28
Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents
CompletedNCT03445468
Start: 2017-09-20End: 2018-08-30Updated: 2020-05-11